23.4 C
Houston
Sunday, February 28, 2021

Study: Drug Improves Survival for Kidney Cancer

The drug cabozantinib is more effective than two similar drugs, as well as the current standard treatment, in extending the lives of patients with a rare and deadly type of kidney cancer, according to a new study.

The cancer is called metastatic papillary kidney cancer. There are currently no effective treatments for it. A previous study of 38 patients found that the average survival rate was just eight months after diagnosis.

These findings could change how the cancer is treated, the research suggested.

“We still have a long way to go to help make patients’ lives longer and better, but we do have a new standard treatment for these rare cancer patients,” said study author Dr. Sumanta Pal, a clinical professor of medical oncology at City of Hope Cancer Center in Duarte, Calif. She’s also a researcher in the SWOG Cancer Research Network.

- Advertisement -

Mutations in the MET gene are a hallmark of this type of this kidney cancer, and new drugs target the MET gene, along with other important signaling pathways.

In this study of 147 patients, researchers compared three MET target drugs — cabozantinib, crizotinib, and savolitinib — with the current standard treatment, sunitinib, a receptor tyrosine inhibitor.

The patients, most of whom hadn’t received any prior treatment, were randomly assigned to receive one of the four treatments.

Progression-free survival (the time it took before the cancer returned or spread) was a median of 5.6 months in the sunitinib group, and much shorter in the savolitinib and crizotinib groups.

However, it was 9.2 months in the cabozantinib group, and 23% of those patients had a significant reduction in the size of their tumor, versus 4% of those in the sunitinib group, the SWOG Cancer Research Network study found.

“The magnitude of the response was surprising,” Pal added in a SWOG/City of Hope news release. 

The study was presented earlier this month at a virtual American Society of Clinical Oncology meeting and published simultaneously in The Lancet journal.

SWOG Cancer Research Network is part of the U.S. National Cancer Institute’s National Clinical Trials Network. City of Hope is an NCI-designated comprehensive cancer care center.

Newsmax

Latest news

NY Democrat State Officials Call for Gov. Cuomo to Resign Over Inappropriate Comments, But Not For Killing Seniors

At least two Democrat state legislatures called for New York Governor Andrew Cuomo to resign on Saturday over a second woman coming forward about...

Wayne LaPierre at CPAC: Leftists ‘Would Rather Kill the 2A than Save Lives’

While speaking Sunday at CPAC 2021, the NRA’s Wayne LaPierre suggested leftist politicians “would rather kill the Second Amendment than save lives.” LaPierre referenced President...

Trump ‘will be on the ballot in 2024’

Former White House trade adviser Peter Navarro is confident former President Donald Trump will...

“Socialism On A Global Scale”: Sky News Host Demolishes Davos Elites And ‘Great Reset’ Scheme

Sky News Australia host Cory Bernardi has just taken a flamethrower to the global elite, telling us we need to be mindful "of any...

Related news

Growing evidence that coronavirus vaccines stop transmission promises return to normal

The news about coronavirus vaccines and infection continues to improve. ...

Kamala Harris is facing the consequences of her dangerous anti-vaccine rhetoric

For months, health experts warned that distributing the coronavirus vaccines would be the...

FDA experts recommend Johnson & Johnson single-dose vaccine, setting up imminent authorization

A panel of vaccine experts has voted unanimously to recommend authorization of Johnson...

Owner of luxury linen company Kearsley knows how to survive tough times

For Heather Wolf, 2019 was proving to be a big year for her business,...

Serious cases of reinfection in nursing homes suggests immunity in seniors might not last, CDC says

Five seniors in a Kentucky nursing home who'd previously been diagnosed with COVID-19...

Kamala Harris describes coronavirus vaccine side effects for first time

Vice President Kamala Harris described for the first time the side effects she experienced...

Pfizer testing third dose of vaccine to protect against coronavirus variants

Pfizer has announced that it will be testing a third dose of its coronavirus...